Immunovia Publ (Sweden) Buy Hold or Sell Recommendation
| IMMNOV Stock | SEK 0.63 0.01 1.61% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Immunovia publ AB is 'Strong Sell'. Macroaxis provides Immunovia Publ buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding IMMNOV positions.
Check out Immunovia Publ Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Immunovia and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Immunovia publ AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Immunovia |
Execute Immunovia Publ Buy or Sell Advice
The Immunovia recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Immunovia publ AB. Macroaxis does not own or have any residual interests in Immunovia publ AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Immunovia Publ's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Immunovia Publ Trading Alerts and Improvement Suggestions
| Immunovia publ AB generated a negative expected return over the last 90 days | |
| Immunovia publ AB has high historical volatility and very poor performance | |
| Immunovia publ AB has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 844 K. Net Loss for the year was (166.63 M) with profit before overhead, payroll, taxes, and interest of 15.81 M. | |
| Immunovia publ AB has accumulated about 359.85 M in cash with (152.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 18.42, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 36.0% of the company shares are held by company insiders |
Immunovia Publ Returns Distribution Density
The distribution of Immunovia Publ's historical returns is an attempt to chart the uncertainty of Immunovia Publ's future price movements. The chart of the probability distribution of Immunovia Publ daily returns describes the distribution of returns around its average expected value. We use Immunovia publ AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Immunovia Publ returns is essential to provide solid investment advice for Immunovia Publ.
| Mean Return | -0.23 | Value At Risk | -6.56 | Potential Upside | 7.55 | Standard Deviation | 9.38 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Immunovia Publ historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Immunovia Publ Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Immunovia Publ or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Immunovia Publ's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Immunovia stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.21 | |
β | Beta against Dow Jones | -0.27 | |
σ | Overall volatility | 9.49 | |
Ir | Information ratio | -0.04 |
Immunovia Publ Volatility Alert
Immunovia publ AB is displaying above-average volatility over the selected time horizon. Immunovia publ AB is a potential penny stock. Although Immunovia Publ may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Immunovia publ AB. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Immunovia instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Immunovia Publ Fundamentals Vs Peers
Comparing Immunovia Publ's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Immunovia Publ's direct or indirect competition across all of the common fundamentals between Immunovia Publ and the related equities. This way, we can detect undervalued stocks with similar characteristics as Immunovia Publ or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Immunovia Publ's fundamental indicators could also be used in its relative valuation, which is a method of valuing Immunovia Publ by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Immunovia Publ to competition |
| Fundamentals | Immunovia Publ | Peer Average |
| Return On Equity | -0.38 | -0.31 |
| Return On Asset | -0.26 | -0.14 |
| Operating Margin | (201.30) % | (5.51) % |
| Current Valuation | 536.89 M | 16.62 B |
| Shares Outstanding | 22.63 M | 571.82 M |
| Shares Owned By Insiders | 36.15 % | 10.09 % |
| Shares Owned By Institutions | 4.60 % | 39.21 % |
| Price To Earning | (57.93) X | 28.72 X |
| Price To Book | 2.21 X | 9.51 X |
| Price To Sales | 683.47 X | 11.42 X |
| Revenue | 844 K | 9.43 B |
| Gross Profit | 15.81 M | 27.38 B |
| EBITDA | (135.47 M) | 3.9 B |
| Net Income | (166.63 M) | 570.98 M |
| Cash And Equivalents | 359.85 M | 2.7 B |
| Cash Per Share | 18.42 X | 5.01 X |
| Total Debt | 27.16 M | 5.32 B |
| Debt To Equity | 7.80 % | 48.70 % |
| Current Ratio | 14.26 X | 2.16 X |
| Book Value Per Share | 13.09 X | 1.93 K |
| Cash Flow From Operations | (152.65 M) | 971.22 M |
| Earnings Per Share | (7.80) X | 3.12 X |
| Target Price | 110.0 | |
| Number Of Employees | 64 | 18.84 K |
| Beta | 1.29 | -0.15 |
| Market Capitalization | 479.62 M | 19.03 B |
| Total Asset | 493.81 M | 29.47 B |
| Z Score | 10.2 | 8.72 |
| Net Asset | 493.81 M |
Immunovia Publ Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Immunovia . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 70635.8 | |||
| Daily Balance Of Power | 0.3333 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 0.63 | |||
| Day Typical Price | 0.63 | |||
| Price Action Indicator | 0.01 | |||
| Period Momentum Indicator | 0.01 |
About Immunovia Publ Buy or Sell Advice
When is the right time to buy or sell Immunovia publ AB? Buying financial instruments such as Immunovia Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Immunovia Publ in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Food Products Thematic Idea Now
Food Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Food Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Food Products Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Immunovia Stock
Immunovia Publ financial ratios help investors to determine whether Immunovia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Immunovia with respect to the benefits of owning Immunovia Publ security.